# Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

> **NCT02737046** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 15 (actual)

## Conditions studied

- Adult T-cell Leukemia-Lymphoma
- ATLL

## Interventions

- **DRUG:** Belinostat
- **DRUG:** Zidovudine
- **DRUG:** Interferon-Alfa-2b
- **DRUG:** Pegylated Interferon-Alfa-2b
- **DRUG:** Lymphodepleting Therapy

## Key facts

- **NCT ID:** NCT02737046
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737046, "Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02737046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*